DIABETES & PANCREATITIS SerpinB1 Promotes Pancreatic β Cell Proliferation Using proteomics the authors showed that serpinB1, a protease inhibitor, which is abundant in the hepatocyte secretome and sera derived from liver insulin receptor knockout mice, is the liver-derived secretory protein that regulates β cell proliferation in humans, mice, and zebrafish. [Cell Metab] Abstract | Graphical Abstract Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer Scientists showed that generation-3 OH-terminated poly(amidoamine) dendrimer, a polymeric nanoparticle, can effectively halt the aggregation of human islet amyloid polypeptide (hIAPP, or amylin) and shut down hIAPP toxicity in pancreatic MIN6 and NIT-1 cells as well as in mouse islets. [Small] Abstract Inhibition of the MAP3 Kinase Tpl2 Protects Rodent and Human β-Cells from Apoptosis and Dysfunction Induced by Cytokines and Enhances Anti-Inflammatory Actions of Exendin-4 Scientists demonstrated that tumor progression locus 2 (Tpl2) is expressed in INS-1E β-cells, mouse and human islets, is activated and upregulated by cytokines and mediates ERK1/2, JNK and p38 activation. Tpl2 inhibition protects β-cells, mouse and human islets from cytokine-induced apoptosis and preserves glucose-induced insulin secretion in mouse and human islets exposed to cytokines. [Cell Death Dis] Full Article PANCREATIC CANCER Functional Annotation of Rare Gene Aberration Drivers of Pancreatic Cancer Investigators describe a platform enabling functionalization of rare gene mutations through their high-throughput construction, molecular barcoding and delivery to cancer models for in vivo tumor driver screens. They apply these technologies to identify oncogenic drivers of pancreatic ductal adenocarcinoma. [Nat Commun] Full Article A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis Expression of tumor-associated MUC1 (tMUC1) positively correlated with neuropilin-1 levels in human and mouse pancreatic ductal adenocarcinoma (PDA). Further, tMUC1hi PDA cells secreted high levels of vascular endothelial growth factor (VEGF) and expressed high levels of VEGF receptor 2 (VEGFR2) and its phosphorylated forms as compared with tMUC1low/null PDA. [Oncogene] Abstract Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities CDK4/6 inhibition stimulated glycolytic and oxidative metabolism and was associated with an increase in mTORC1 activity. MTOR and MEK inhibitors potently cooperate with CDK4/6 inhibition in eliciting cell-cycle exit. However, MTOR inhibition fully suppressed metabolism and yielded apoptosis and suppression of tumor growth in xenograft models. [Cell Rep] Full Article | Graphical Abstract | Press Release β2-Adrenergic Receptor Signaling Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Progression through Activating PCBP2-dependent C-myc Expression Researchers identified poly(rC)-binding protein 2 (PCBP2) as a novel binding partner for β2-adrenergic receptor (β2-AR) using immunoprecipitation-mass spectrometry (IP-MS) approach. The association between β2-AR and PCBP2 was verified using reciprocal immunoprecipitation. Additionally, they found significant interaction and co-localization of the two proteins in the presence of β2-AR agonist in Panc-1 and Bxpc3 pancreatic ductal adenocarcinoma cells. [Cancer Lett] Abstract Nimbolide Inhibits Pancreatic Cancer Growth and Metastasis through ROS-Mediated Apoptosis and Inhibition of Epithelial-to-Mesenchymal Transition Scientists assessed the anticancer properties of nimbolide against pancreatic cancer. Data reveal that nimbolide induces excessive generation of reactive oxygen species (ROS), thereby regulating both apoptosis and autophagy in pancreatic cancer cells. [Sci Rep] Full Article |